Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4876151
Max Phase: Preclinical
Molecular Formula: C11H11NO5S
Molecular Weight: 269.28
Molecule Type: Unknown
Associated Items:
ID: ALA4876151
Max Phase: Preclinical
Molecular Formula: C11H11NO5S
Molecular Weight: 269.28
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOc1cccc2cc(S(N)(=O)=O)c(=O)oc12
Standard InChI: InChI=1S/C11H11NO5S/c1-2-16-8-5-3-4-7-6-9(18(12,14)15)11(13)17-10(7)8/h3-6H,2H2,1H3,(H2,12,14,15)
Standard InChI Key: LXRSALAUTHMGJG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 269.28 | Molecular Weight (Monoisotopic): 269.0358 | AlogP: 0.84 | #Rotatable Bonds: 3 |
Polar Surface Area: 99.60 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.39 | CX Basic pKa: | CX LogP: 0.65 | CX LogD: 0.39 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.83 | Np Likeness Score: -0.98 |
1. Dar'in D, Kantin G, Kalinin S, Sharonova T, Bunev A, Ostapenko GI, Nocentini A, Sharoyko V, Supuran CT, Krasavin M.. (2021) Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent., 222 [PMID:34147910] [10.1016/j.ejmech.2021.113589] |
Source(1):